These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 23538201

  • 21. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
    Sugizaki T, Watanabe M, Horai Y, Kaneko-Iwasaki N, Arita E, Miyazaki T, Morimoto K, Honda A, Irie J, Itoh H.
    Endocrinology; 2014 Aug; 155(8):2810-9. PubMed ID: 24773344
    [Abstract] [Full Text] [Related]

  • 22. Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.
    Nozaki Y, Fujita K, Yoneda M, Wada K, Shinohara Y, Takahashi H, Kirikoshi H, Inamori M, Kubota K, Saito S, Mizoue T, Masaki N, Nagashima Y, Terauchi Y, Nakajima A.
    J Hepatol; 2009 Sep; 51(3):548-56. PubMed ID: 19596472
    [Abstract] [Full Text] [Related]

  • 23. Ezetimibe impairs uptake of dietary cholesterol oxidation products and reduces alterations in hepatic cholesterol metabolism and antioxidant function in rats.
    Terunuma S, Kumata N, Osada K.
    Lipids; 2013 Jun; 48(6):587-95. PubMed ID: 23588779
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.
    Van Rooyen DM, Gan LT, Yeh MM, Haigh WG, Larter CZ, Ioannou G, Teoh NC, Farrell GC.
    J Hepatol; 2013 Jul; 59(1):144-52. PubMed ID: 23500152
    [Abstract] [Full Text] [Related]

  • 25. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
    Hsu SC, Huang CJ.
    J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
    [Abstract] [Full Text] [Related]

  • 26. High dietary iron reduces transporters involved in iron and manganese metabolism and increases intestinal permeability in calves.
    Hansen SL, Ashwell MS, Moeser AJ, Fry RS, Knutson MD, Spears JW.
    J Dairy Sci; 2010 Feb; 93(2):656-65. PubMed ID: 20105537
    [Abstract] [Full Text] [Related]

  • 27. Differential regulation of hepatic gene expression by starvation versus refeeding following a high-sucrose or high-fat diet.
    Ryu MH, Sohn HS, Heo YR, Moustaid-Moussa N, Cha YS.
    Nutrition; 2005 Apr; 21(4):543-52. PubMed ID: 15811778
    [Abstract] [Full Text] [Related]

  • 28. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats.
    Xu G, Huang X, Qiu L, Wu J, Hu Y.
    Asia Pac J Clin Nutr; 2007 Apr; 16 Suppl 1():313-7. PubMed ID: 17392126
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice.
    Kawanishi N, Yano H, Mizokami T, Takahashi M, Oyanagi E, Suzuki K.
    Brain Behav Immun; 2012 Aug; 26(6):931-41. PubMed ID: 22554494
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process.
    Yoshimatsu M, Terasaki Y, Sakashita N, Kiyota E, Sato H, van der Laan LJ, Takeya M.
    Int J Exp Pathol; 2004 Dec; 85(6):335-43. PubMed ID: 15566430
    [Abstract] [Full Text] [Related]

  • 35. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A.
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [Abstract] [Full Text] [Related]

  • 36. Vascular protective effects of ezetimibe in ApoE-deficient mice.
    Nakagami H, Osako MK, Takami Y, Hanayama R, Koriyama H, Mori M, Hayashi H, Shimizu H, Morishita R.
    Atherosclerosis; 2009 Mar; 203(1):51-8. PubMed ID: 18603252
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hepatic lipid and carbohydrate metabolism in rats fed a commercial mixture of conjugated linoleic acids (Clarinol G-80).
    Giudetti AM, Beynen AC, Lemmens AG, Gnoni GV, Geelen MJ.
    Eur J Nutr; 2005 Feb; 44(1):33-9. PubMed ID: 15309462
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.